ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0230

Fatigue and Inflammation in Rheumatoid Arthritis Are Already Disconnected Before Clinical Arthritis Develops

Sarah J.H. Khidir1, Annette H.M van der Helm-van Mil1 and Elise van Mulligen2, 1Leiden University Medical Center, Leiden, Netherlands, 2Erasmus Medical Center, Rotterdam, Netherlands

Meeting: ACR Convergence 2021

Keywords: Clinically Suspect Arthralgia, Fatigue, Inflammation, Magnetic resonance imaging (MRI), rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 6, 2021

Title: Patient Outcomes, Preferences, & Attitudes Poster I: Impact (0225–0240)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: Fatigue is disabling and common in Rheumatoid Arthritis (RA); the causation of fatigue in RA is multidimensional and only partially explained by inflammation. The question arises how fatigue develops in the preclinical phases of RA, and how inflammation is related to fatigue in the pre-arthritis phase. We hypothesized that inflammation explains fatigue to a greater extent at the beginning of developing RA, when processes are not yet chronified. Our aims are therefore (1) to describe the course of fatigue in patients with clinically suspect arthralgia (CSA) towards progression to RA, and (2) to assess the correlation between fatigue and inflammation in CSA patients and compare this to RA at the time of diagnosis.

Methods: 595 CSA patients were included between April 2012 and May 2020 in the Leiden CSA cohort and were followed for the development of RA. Additionally, baseline data of 710 consecutive early RA patients who were included in the Leiden Early Arthritis Cohort between August 2010 and March 2020, were studied. Inflammation was defined by MRI detected inflammation on contrast-enhanced 1.5T-MRI of hand and forefoot (scored according to the RAMRIS-method) and by C reactive protein (CRP) levels, representing local and systemic inflammation, respectively. Fatigue severity was measured on a numerical rating scale (NRS) from 0 (no fatigue) to 10 (extreme fatigue). A linear mixed model was used to analyze whether fatigue increased over time towards the development of RA. Correlations between fatigue and inflammation were studied using Spearman’s rank correlation coefficient.

Results: At first presentation, baseline fatigue (mean (SD)) was 4.5 (3) for patients who developed RA. Over time, fatigue severity increased gradually towards 4.7 ± 3.0 at the time of RA development; (β= -0.08 per month away from arthritis development, p=0.07, Figure 1). Assessing the correlation of fatigue with inflammation at CSA onset in patients who later on developed RA, revealed weak correlations with MRI-detected inflammation (ρ=-0.147, p=0.25) and with CRP-levels (ρ=0.165, p=0.17). For comparison at RA diagnosis, correlations between fatigue severity and inflammation were ρ=-0.074, p=0.09 for MRI-detected inflammation and ρ=0.023, p=0.34 for CRP-levels. Hence, although the correlation coefficients were slightly higher at CSA onset than at RA development, the correlations of fatigue with inflammation were weak at both disease phases.

Conclusion: Fatigue increased gradually during progression from arthralgia to RA. The correlation between fatigue with inflammatory measures in pre-RA patients were slightly higher than in early RA patients, but were still weak. This suggests that fatigue symptoms are largely disentangled from inflammation, even in the pre-arthritis phase of RA.

Figure 1. Fatigue in the months preceding development of Rheumatoid Arthritis


Disclosures: S. Khidir, None; A. van der Helm-van Mil, None; E. van Mulligen, None.

To cite this abstract in AMA style:

Khidir S, van der Helm-van Mil A, van Mulligen E. Fatigue and Inflammation in Rheumatoid Arthritis Are Already Disconnected Before Clinical Arthritis Develops [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/fatigue-and-inflammation-in-rheumatoid-arthritis-are-already-disconnected-before-clinical-arthritis-develops/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/fatigue-and-inflammation-in-rheumatoid-arthritis-are-already-disconnected-before-clinical-arthritis-develops/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology